ArticleBlood advances2026

TCRVβ-targeting antibody-drug conjugates as a novel strategy to eliminate malignant T cells in T cell cancers.

Chella Krishna Vadivel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.